Application of monoclonal antibodies for the diagnostic and therapeutic targeting of human tumors with a necrotic component

Application of monoclonal antibodies for the diagnostic and therapeutic targeting of human tumors with a necrotic component

Due to a unique structure of tumors, TNT antibodies can bind with a great number of target cells in the hypoxic core of the injury zone. Long-standing laboratory and clinical research gave evidence for the utility of histone/DNA complexes as stable insoluble antigens available for binding with TNT a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Russian journal of general chemistry 2014-02, Vol.84 (2), p.345-356
Hauptverfasser: Parseghian, M. H., Mechetner, E., Osidak, M. S., Domogatskii, S. P.
Format: Artikel
Sprache:eng
Schlagworte:
Chemistry
Chemistry and Materials Science
Chemistry/Food Science
Supplement: Rossiiskii Khimicheskii Zhurnal-Zhurnal Rossiiskogo Khimicheskogo Obshchestva im. D.I. Mendeleeva (Russian Chemistry Journal)
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 356
container_issue 2
container_start_page 345
container_title Russian journal of general chemistry
container_volume 84
creator Parseghian, M. H.
Mechetner, E.
Osidak, M. S.
Domogatskii, S. P.
description Due to a unique structure of tumors, TNT antibodies can bind with a great number of target cells in the hypoxic core of the injury zone. Long-standing laboratory and clinical research gave evidence for the utility of histone/DNA complexes as stable insoluble antigens available for binding with TNT antibodies in necrotic (but not in healthy!) cells. The ability of TNT antibodies to selectively accumulate in the necrotic cores of most solid tumors allows detection and killing of primary and metastatic tumors of any origin.
doi_str_mv 10.1134/S1070363214020364
format Article
fullrecord <record><control><sourceid>crossref_sprin</sourceid><recordid>TN_cdi_crossref_primary_10_1134_S1070363214020364</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1134_S1070363214020364</sourcerecordid><originalsourceid>FETCH-LOGICAL-c288t-25d2154465b33ee5696215899d825add393e2865be19af73eb504e4c69e428063</originalsourceid><addsrcrecordid>eNp9UMtKxDAUDaLgOPoB7vID1bwnXQ6DLxhwoa5L2t52MrRJSVJE_HlTxp3g6p57z4PLQeiWkjtKubh_o2RDuOKMCsIyEGdoRRXRBeeSnGec6WLhL9FVjEdCKCGKrdD3dpoG25hkvcO-w6N3vhm8MwM2LtnatxYi7nzA6QC4taZ3PibbZLZdTsFMMC97MqGHZF2_pBzm0Tic5tGHiD9tOmCDHTTBL8rGj5N34NI1uujMEOHmd67Rx-PD--652L8-vey2-6JhWqeCyZZRKYSSNecAUpUq77osW82kaVtecmA6s0BL02041JIIEI0qQTBNFF8jesrND8QYoKumYEcTvipKqqW96k972cNOnpi1rodQHf0cci3xH9MPS5NzBA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Application of monoclonal antibodies for the diagnostic and therapeutic targeting of human tumors with a necrotic component</title><source>Springer Nature - Complete Springer Journals</source><creator>Parseghian, M. H. ; Mechetner, E. ; Osidak, M. S. ; Domogatskii, S. P.</creator><creatorcontrib>Parseghian, M. H. ; Mechetner, E. ; Osidak, M. S. ; Domogatskii, S. P.</creatorcontrib><description>Due to a unique structure of tumors, TNT antibodies can bind with a great number of target cells in the hypoxic core of the injury zone. Long-standing laboratory and clinical research gave evidence for the utility of histone/DNA complexes as stable insoluble antigens available for binding with TNT antibodies in necrotic (but not in healthy!) cells. The ability of TNT antibodies to selectively accumulate in the necrotic cores of most solid tumors allows detection and killing of primary and metastatic tumors of any origin.</description><identifier>ISSN: 1070-3632</identifier><identifier>EISSN: 1608-3350</identifier><identifier>DOI: 10.1134/S1070363214020364</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Chemistry ; Chemistry and Materials Science ; Chemistry/Food Science ; Supplement: Rossiiskii Khimicheskii Zhurnal-Zhurnal Rossiiskogo Khimicheskogo Obshchestva im. D.I. Mendeleeva (Russian Chemistry Journal)</subject><ispartof>Russian journal of general chemistry, 2014-02, Vol.84 (2), p.345-356</ispartof><rights>Pleiades Publishing, Ltd. 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c288t-25d2154465b33ee5696215899d825add393e2865be19af73eb504e4c69e428063</citedby><cites>FETCH-LOGICAL-c288t-25d2154465b33ee5696215899d825add393e2865be19af73eb504e4c69e428063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1134/S1070363214020364$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1134/S1070363214020364$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Parseghian, M. H.</creatorcontrib><creatorcontrib>Mechetner, E.</creatorcontrib><creatorcontrib>Osidak, M. S.</creatorcontrib><creatorcontrib>Domogatskii, S. P.</creatorcontrib><title>Application of monoclonal antibodies for the diagnostic and therapeutic targeting of human tumors with a necrotic component</title><title>Russian journal of general chemistry</title><addtitle>Russ J Gen Chem</addtitle><description>Due to a unique structure of tumors, TNT antibodies can bind with a great number of target cells in the hypoxic core of the injury zone. Long-standing laboratory and clinical research gave evidence for the utility of histone/DNA complexes as stable insoluble antigens available for binding with TNT antibodies in necrotic (but not in healthy!) cells. The ability of TNT antibodies to selectively accumulate in the necrotic cores of most solid tumors allows detection and killing of primary and metastatic tumors of any origin.</description><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Chemistry/Food Science</subject><subject>Supplement: Rossiiskii Khimicheskii Zhurnal-Zhurnal Rossiiskogo Khimicheskogo Obshchestva im. D.I. Mendeleeva (Russian Chemistry Journal)</subject><issn>1070-3632</issn><issn>1608-3350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9UMtKxDAUDaLgOPoB7vID1bwnXQ6DLxhwoa5L2t52MrRJSVJE_HlTxp3g6p57z4PLQeiWkjtKubh_o2RDuOKMCsIyEGdoRRXRBeeSnGec6WLhL9FVjEdCKCGKrdD3dpoG25hkvcO-w6N3vhm8MwM2LtnatxYi7nzA6QC4taZ3PibbZLZdTsFMMC97MqGHZF2_pBzm0Tic5tGHiD9tOmCDHTTBL8rGj5N34NI1uujMEOHmd67Rx-PD--652L8-vey2-6JhWqeCyZZRKYSSNecAUpUq77osW82kaVtecmA6s0BL02041JIIEI0qQTBNFF8jesrND8QYoKumYEcTvipKqqW96k972cNOnpi1rodQHf0cci3xH9MPS5NzBA</recordid><startdate>20140201</startdate><enddate>20140201</enddate><creator>Parseghian, M. H.</creator><creator>Mechetner, E.</creator><creator>Osidak, M. S.</creator><creator>Domogatskii, S. P.</creator><general>Pleiades Publishing</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20140201</creationdate><title>Application of monoclonal antibodies for the diagnostic and therapeutic targeting of human tumors with a necrotic component</title><author>Parseghian, M. H. ; Mechetner, E. ; Osidak, M. S. ; Domogatskii, S. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c288t-25d2154465b33ee5696215899d825add393e2865be19af73eb504e4c69e428063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Chemistry/Food Science</topic><topic>Supplement: Rossiiskii Khimicheskii Zhurnal-Zhurnal Rossiiskogo Khimicheskogo Obshchestva im. D.I. Mendeleeva (Russian Chemistry Journal)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Parseghian, M. H.</creatorcontrib><creatorcontrib>Mechetner, E.</creatorcontrib><creatorcontrib>Osidak, M. S.</creatorcontrib><creatorcontrib>Domogatskii, S. P.</creatorcontrib><collection>CrossRef</collection><jtitle>Russian journal of general chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Parseghian, M. H.</au><au>Mechetner, E.</au><au>Osidak, M. S.</au><au>Domogatskii, S. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Application of monoclonal antibodies for the diagnostic and therapeutic targeting of human tumors with a necrotic component</atitle><jtitle>Russian journal of general chemistry</jtitle><stitle>Russ J Gen Chem</stitle><date>2014-02-01</date><risdate>2014</risdate><volume>84</volume><issue>2</issue><spage>345</spage><epage>356</epage><pages>345-356</pages><issn>1070-3632</issn><eissn>1608-3350</eissn><abstract>Due to a unique structure of tumors, TNT antibodies can bind with a great number of target cells in the hypoxic core of the injury zone. Long-standing laboratory and clinical research gave evidence for the utility of histone/DNA complexes as stable insoluble antigens available for binding with TNT antibodies in necrotic (but not in healthy!) cells. The ability of TNT antibodies to selectively accumulate in the necrotic cores of most solid tumors allows detection and killing of primary and metastatic tumors of any origin.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><doi>10.1134/S1070363214020364</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1070-3632
ispartof Russian journal of general chemistry, 2014-02, Vol.84 (2), p.345-356
issn 1070-3632
1608-3350
language eng
recordid cdi_crossref_primary_10_1134_S1070363214020364
source Springer Nature - Complete Springer Journals
subjects Chemistry
Chemistry and Materials Science
Chemistry/Food Science
Supplement: Rossiiskii Khimicheskii Zhurnal-Zhurnal Rossiiskogo Khimicheskogo Obshchestva im. D.I. Mendeleeva (Russian Chemistry Journal)
title Application of monoclonal antibodies for the diagnostic and therapeutic targeting of human tumors with a necrotic component
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T23%3A18%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref_sprin&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Application%20of%20monoclonal%20antibodies%20for%20the%20diagnostic%20and%20therapeutic%20targeting%20of%20human%20tumors%20with%20a%20necrotic%20component&rft.jtitle=Russian%20journal%20of%20general%20chemistry&rft.au=Parseghian,%20M.%20H.&rft.date=2014-02-01&rft.volume=84&rft.issue=2&rft.spage=345&rft.epage=356&rft.pages=345-356&rft.issn=1070-3632&rft.eissn=1608-3350&rft_id=info:doi/10.1134/S1070363214020364&rft_dat=%3Ccrossref_sprin%3E10_1134_S1070363214020364%3C/crossref_sprin%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true